Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

被引：0
作者：
Gennatas, C
Mouratidou, D
Tsavaris, N
Andreadis, C
Michalaki, V
Psychogios, J
Poulakaki, N
Gennatas, S
机构：
[1] Univ Athens, Areteion Hosp, Athens, Greece
[2] Theagenion Krankenhauses, Thessaloniki, Greece
[3] Univ Athens, Laiko Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：63S / 63S
页数：1
相关论文
共 50 条
  • [31] Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
    Park, In Hae
    Ro, Jungsil
    Lee, Keun Seok
    Kim, Shi Nae
    Yun, Young Ho
    Nam, Byung Ho
    [J]. INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 659 - 669
  • [32] Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
    In Hae Park
    Jungsil Ro
    Keun Seok Lee
    Shi Nae Kim
    Young Ho Yun
    Byung Ho Nam
    [J]. Investigational New Drugs, 2010, 28 : 659 - 669
  • [33] Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline-and taxane-pretreated breast cancer
    Ardavanis, A.
    Kountourakis, P.
    Maliou, S.
    Vassilakopoulou, M.
    Basioukas, S.
    Kyriakou, F.
    Koumna, S.
    Rigatos, G.
    [J]. ANTICANCER RESEARCH, 2007, 27 (4C) : 2989 - 2992
  • [34] Gemcitabine and carboplatin in heavily pretreated metastatic breast cancer: predictive value of breast cancer subtypes
    Natoli, G.
    Nelli, F.
    Moscetti, L.
    D'Auria, G.
    Signorelli, C.
    Chilelli, M. G.
    Padalino, D.
    Massari, A.
    Ruggeri, E. M.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 279 - 279
  • [35] Tailored low-dose gemcitabine-cisplatin combination is a feasible and effective treatment in heavily pretreated advanced breast cancer patients.
    Alés-Martínez, JE
    Hernández, S
    Sánchez-Escribano, R
    Aramburo, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 87S - 87S
  • [36] High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients
    Vici, P
    Capomolla, E
    Foggi, P
    Carpano, S
    Conti, F
    Paoletti, G
    Cauchi, C
    Giacinti, L
    Leonetti, C
    Giannarelli, D
    Lopez, M
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2006, 25 (01): : 39 - 44
  • [37] Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer
    Kosmas, C
    Agelaki, S
    Giannakakis, T
    Mavroudis, D
    Kouroussis, C
    Kalbakis, K
    Papadouris, S
    Souglakos, J
    Malamos, N
    Georgoulias, V
    [J]. ONCOLOGY, 2002, 62 (02) : 103 - 109
  • [38] Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer
    Martinez Marin, Virginia
    Munoz Martin, Andres J.
    Vinuela Beneitez, M. Carmen
    Garcia Alfonso, Pilar
    Alonso Munoz, Antonio
    Perez Manga, Gumersindo
    [J]. MEDICINA CLINICA, 2009, 133 (10): : 371 - 374
  • [39] A phase II study of gemcitabine (G) in heavily pretreated breast cancer (BC)
    Valerio, Maria Rosaria
    Benfante, Biancaluana
    Spinnato, Francesca
    Scibilia, Carla
    Cicero, Giuseppe
    Scaglione, Daniela
    Cocchiara, Anna
    Amato, Carmela
    Cipolla, Calogero
    Graceffa, Giuseppina
    Gebbia, Nicola
    Di Fede, Gaetana
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 14 - 15
  • [40] First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study
    Pectasides, D
    Dimopoulos, MA
    Aravantinos, G
    Kalophonos, HP
    Papacostas, P
    Briasoulis, E
    Cogas, E
    Papadimitriou, C
    Skarlos, D
    Kosmidis, P
    Fountzilas, G
    [J]. ANTICANCER RESEARCH, 2001, 21 (05) : 3575 - 3580
12345